NYSE:MPLN

MultiPlan (MPLN) Stock Price, News & Analysis

$0.61
-0.04 (-6.65%)
(As of 03:45 PM ET)
Today's Range
$0.56
$0.63
50-Day Range
$0.55
$1.12
52-Week Range
$0.53
$2.29
Volume
3.36 million shs
Average Volume
1.67 million shs
Market Capitalization
$391.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

MultiPlan MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
244.8% Upside
$2.00 Price Target
Short Interest
Bearish
6.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of MultiPlan in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.22 out of 5 stars

Medical Sector

888th out of 905 stocks

Business Services, Not Elsewhere Classified Industry

89th out of 90 stocks

MPLN stock logo

About MultiPlan Stock (NYSE:MPLN)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

MPLN Stock Price History

MPLN Stock News Headlines

The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
MPLN Apr 2024 1.000 put
MultiPlan appoints Jerry Hogge as COO
Multiplan FY 2023 Earnings Preview
MultiPlan Announces CEO Succession Plan
See More Headlines
Receive MPLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MultiPlan and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
5/08/2024
Next Earnings (Confirmed)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
2,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+231.5%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-91,700,000.00
Pretax Margin
-11.13%

Debt

Sales & Book Value

Annual Sales
$961.52 million
Cash Flow
$0.41 per share
Book Value
$2.64 per share

Miscellaneous

Free Float
591,533,000
Market Cap
$388.81 million
Optionable
Optionable
Beta
0.67
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Dale A. White (Age 68)
    Executive Chair
    Comp: $1.6M
  • Mr. James M. HeadMr. James M. Head (Age 58)
    Chief Financial Officer
    Comp: $1.05M
  • Mr. Michael C. Kim (Age 58)
    Chief Information Officer
    Comp: $740.35k
  • Mr. Jeffrey A. Doctoroff (Age 55)
    General Counsel & Corporate Secretary
    Comp: $690.31k
  • Ms. Carol H. Nutter (Age 47)
    Chief People Officer
    Comp: $600.59k
  • Mr. Travis S. Dalton (Age 53)
    CEO, President & Director
  • Mr. Jerome W. Hogge III
    Chief Operations Officer
  • Ms. Melissa Humphrey
    Senior Vice President of Marketing & Communications
  • Mr. Alwyn Van Heerdan
    Vice President of Strategy & Corporate Development
  • Mr. Derek Reis-Larson
    Senior Vice President of Claims Pricing Services

MPLN Stock Analysis - Frequently Asked Questions

What is MultiPlan's stock price target for 2024?

0 analysts have issued 12-month target prices for MultiPlan's stock. Their MPLN share price targets range from $2.00 to $2.00. On average, they expect the company's share price to reach $2.00 in the next year. This suggests a possible upside of 244.8% from the stock's current price.
View analysts price targets for MPLN
or view top-rated stocks among Wall Street analysts.

How have MPLN shares performed in 2024?

MultiPlan's stock was trading at $1.44 at the beginning of the year. Since then, MPLN shares have decreased by 59.7% and is now trading at $0.58.
View the best growth stocks for 2024 here
.

When is MultiPlan's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our MPLN earnings forecast
.

How were MultiPlan's earnings last quarter?

MultiPlan Co. (NYSE:MPLN) released its quarterly earnings results on Thursday, February, 29th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $244.14 million for the quarter. MultiPlan had a negative trailing twelve-month return on equity of 8.31% and a negative net margin of 9.54%.

What guidance has MultiPlan issued on next quarter's earnings?

MultiPlan updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

Who are MultiPlan's major shareholders?

MultiPlan's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Empowered Funds LLC (0.24%) and Empirical Financial Services LLC d.b.a. Empirical Wealth Management (0.01%). Insiders that own company stock include Anthony Colaluca Jr, James M Head, Julie D Klapstein, Mark Tabak and Michael Kim.
View institutional ownership trends
.

How do I buy shares of MultiPlan?

Shares of MPLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MPLN) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners